N/A
N=94
Barrow Nasal Inventory Survey
Pituitary Tumors
Bottom Line
View on ClinicalTrials.gov: NCT01322945 ↗Enrolled (actual)
94
Serious AEs
0.0%
Results posted
Dec 2013
Primary outcome: Primary: Change in Mean Survey Response From Baseline to 90 Days Post Surgery — 17.3; 13.5 units on a scale — p=0.001
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- St. Joseph's Hospital and Medical Center, Phoenix
- Primary completion
- Jun 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Mean Survey Response From Baseline to 90 Days Post Surgery |
17.3; 13.5 | 0.001 sig |
| SECONDARY Test-retest Reliability of the ASK Nasal Inventory |
0.87; 0.95 | — |
Summary
The purpose of this study is to evaluate patient nasal outcome following endo-nasal surgery. This type of surgery is conducted for pituitary and skull base tumors. There is no published data on trauma to the nose during surgery and how it impacts nasal functioning. The investigators propose to develop a survey and administer it to patients before and after surgery to learn about their perception of nasal functioning.
Eligibility Criteria
Inclusion Criteria
- Adults with planned endonasal surgery for pituitary tumor or skull base lesion
Exclusion Criteria
- Children
Data sourced from ClinicalTrials.gov (NCT01322945). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.